We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4592 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 50 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
449
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DnB Asset Management
76
DnB Asset Management
Norway
-$9.54M -177,001 Closed
Swiss National Bank
77
Swiss National Bank
Switzerland
-$9.44M -175,000 Closed
ERSOT
78
Employees Retirement System of Texas
Texas
-$9.27M -172,000 Closed
California State Teachers Retirement System (CalSTRS)
79
California State Teachers Retirement System (CalSTRS)
California
-$9.27M -171,878 Closed
GAM
80
Gotham Asset Management
New York
-$8.23M -152,666 Closed
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
-$8.22M -152,430 Closed
Bank of Montreal
82
Bank of Montreal
Ontario, Canada
-$8.19M -151,924 Closed
RJA
83
Raymond James & Associates
Florida
-$8.07M -149,772 Closed
AIM
84
Alambic Investment Management
California
-$7.81M -144,823 Closed
TD Asset Management
85
TD Asset Management
Ontario, Canada
-$7.72M -143,115 Closed
CS
86
Credit Suisse
Switzerland
-$7.55M -140,100 Closed
VOYA Investment Management
87
VOYA Investment Management
Georgia
-$7.42M -137,671 Closed
PNC Financial Services Group
88
PNC Financial Services Group
Pennsylvania
-$7.39M -137,103 Closed
WG
89
Winton Group
United Kingdom
-$7.35M -136,278 Closed
GIA
90
Gateway Investment Advisers
Ohio
-$7.09M -131,579 Closed
UBS AM
91
UBS AM
Illinois
-$7.09M -131,573 Closed
TA
92
Teachers Advisors
New York
-$7.06M -130,950 Closed
PAM
93
Panagora Asset Management
Massachusetts
-$6.34M -117,538 Closed
LCM
94
Laurion Capital Management
New York
-$6.32M -117,266 Closed
BNP Paribas Financial Markets
95
BNP Paribas Financial Markets
France
-$6.02M -111,665 Closed
Citigroup
96
Citigroup
New York
-$5.89M -109,342 Closed
CCP
97
Clough Capital Partners
Massachusetts
-$5.86M -108,600 Closed
AA
98
Ancora Advisors
Ohio
-$5.81M -107,685 Closed
GLA
99
Great Lakes Advisors
Illinois
-$5.75M -106,662 Closed
EVM
100
Eaton Vance Management
Massachusetts
-$5.57M -103,253 Closed

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.